Uses of Rensaid 200

Rensaid 200 medicine has the main active ingredient Etodolac with 200mg content and other excipients in sufficient quantity. Rensaid 200 is a non-steroid analgesic, antipyretic and anti-inflammatory drug.

This is a drug made in the form of hard capsules, suitable for direct oral use. Packing is a box of 3 blisters or a box of 10 blisters, each blister contains 10 capsules.
Pharmacokinetics of the active ingredient Etodolac:
Absorption: the active substance is rapidly absorbed from the gastrointestinal tract. Metabolism: Etodolac is metabolized mainly in the liver. Elimination ability: the active substance is eliminated mainly through the urine. The effect of the active ingredient Etodolac is antipyretic, analgesic, anti-inflammatory, but the strongest effect is anti-inflammatory.

Rensaid 200 is used in the treatment of specific diseases as follows:
Treatment of osteoarthritis, acute gout attacks or pseudo-gout. Treatment of pain after tooth extraction, pain after surgery, pain after episiotomy. Dysmenorrhea treatment. Treatment of acute musculoskeletal pain of various etiologies.

Dosage for treatment of osteoarthritis, Gout total dose up to 1200 mg/day. For users weighing less than 60 kg of body weight, the maximum total dose is 20 mg/kg/day. For pain treatment in dentistry, the dose is 200 mg/day, used 3 to 4 times/day. For the treatment of extensor tendonitis, bursitis, elbow fasciitis, tenosynovitis, plantar fasciitis and pain after episiotomy 400mg, used 2 to 3 times a day. For people who overdosed on Rensaid 200, there have been no reports of symptoms associated with an overdose of Etodolac in clinical trials. Acute overdosage with nonsteroidal anti-inflammatory drugs is generally very rare, leading to lethargy, somnolence, nausea, vomiting or epigastric pain or gastrointestinal bleeding. When drug overdose may experience high blood pressure, acute kidney failure...
In the case of overdose of non-steroidal anti-inflammatory drugs, mainly symptomatic and supportive treatment and currently there is no antidote. specific for drug overdose.

Adverse effects of Rensaid 200 are usually mild and transient including:
Gastrointestinal effects that have occurred include: abdominal pain, digestive disorders constipation, diarrhea, dyspepsia, bloating gas, heartburn, nausea, peptic ulcer disease, vomiting. Other cases include: abnormal kidney function, anemia, dizziness, edema, increased liver enzymes, headache, increased bleeding time, itching, skin rash, tinnitus. Take the initiative to stop using Rensaid 200 and consult your doctor if you notice any of the following rare but serious side effects: black stools, abdominal pain, coffee grounds-colored vomiting, chest pain, shortness of breath, unusual sweating, confusion, slurred speech or tongue, sudden vision changes.
You should also proactively notify your treating doctor of any unwanted effects you experience during treatment with this drug for proper and specific treatment.

Stomach antacids can reduce the concentration of Etodolac in the blood. Co-administration of Rensaid 200 with Aspirin and other non-steroidal anti-inflammatory drugs increases the unwanted effects of Rensaid 200. Co-administration of Rensaid 200 with warfarin reduces the protein binding of warfarin. The active ingredient Etodolac when used with cycloserin, digoxin, lithium, methotrexate will reduce the clearance of these substances and increase the possible toxicity.

6.1. Contraindications of the drug Rensaid 200 People with hypersensitivity to the main ingredient Etodolac or any other ingredient of the drug. People with a history of asthma, urticaria or other allergic-type reactions after taking aspirin or other non-steroidal anti-inflammatory agents. People with severe liver failure or severe kidney disease. Children under 15 years of age, as the safety and effectiveness of this medicine in children have not been established. Women in the last 3 months of pregnancy and women in the lactation period. Renal function and urinary excretion should be closely monitored in patients with heart failure, liver failure, chronic renal failure or those taking diuretics. The hemoglobin and hematocrit should be checked periodically for signs of anemia that can sometimes occur in people taking non-steroidal anti-inflammatory drugs. Users of the drug may give a false-positive reaction for bilirubin - urine due to the presence of phenolic metabolites of etodolac in the urine. 6.2. Precautions of Rensaid 200 Drugs containing Etodolac should be used with caution in people with a history of ischemic heart disease or cerebrovascular disease.
Rensaid 200 should also be used with caution in people with risk factors for cardiovascular or peripheral artery disease, a history of gastrointestinal bleeding, impaired liver or kidney function, a history of diseases such as asthma or allergies. There are currently no studies demonstrating the effects of Etodolac on the ability to drive or use machines. Above is all information about Rensaid 200, patients need to carefully read the instructions for use, consult a doctor / pharmacist before using. Absolutely do not arbitrarily buy Rensaid 200 to treat diseases at home, because there may be unwanted side effects on health.